Cytel USA

Sort by

Más recientes

Populares

Eugm 2012 unknown - incivex drug development process overview road to finding a cure for hcv genotype 1

Eugm 2012 pritchett - application of adaptive sample size re-estimation in event outcome confirmatory trials - 2012 eugm

Eugm 2012 oneill - perspective on the current environment for adaptive clinical trials - 2012 eugm

Eugm 2012 mehta - future plans for east - 2012 eugm

Eugm 2012 jemiai - introduction to east architect

Eugm 2012 gaydos - design and analysis approaches to evaluate cardiovascular risk

Eugm 2012 demets - clinical trials and the impact of regulations

Eugm 2011 pocock - dm cs-and-adaptive-trials

Eugm 2011 mehta - execution of adaptive trials operational considerations

Eugm 2011 mehta - adaptive designs for phase 3 oncology trials

EUGM 2011 | JEMIAI

EUGM 2011 | DAY | Experiences with interim analyses and dm cs

EUGM 2011 | JEHL | group sequential designs with 2 time to event endpoints

EUGM 2011| Fretault | Use of bayesian approach in phase ii

EUGM 2011 | DARCHY | Deployment & use of east within sanofi r & d